BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21281435)

  • 1. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
    Wagenknecht LE; Palmer ND; Bowden DW; Rotter JI; Norris JM; Ziegler J; Chen YD; Haffner S; Scherzinger A; Langefeld CD
    Liver Int; 2011 Mar; 31(3):412-6. PubMed ID: 21281435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus.
    Cox AJ; Wing MR; Carr JJ; Hightower RC; Smith SC; Xu J; Wagenknecht LE; Bowden DW; Freedman BI
    Diabetes Metab; 2011 Nov; 37(5):452-5. PubMed ID: 21665509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
    Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
    Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.
    Wagenknecht LE; Scherzinger AL; Stamm ER; Hanley AJ; Norris JM; Chen YD; Bryer-Ash M; Haffner SM; Rotter JI
    Obesity (Silver Spring); 2009 Jun; 17(6):1240-6. PubMed ID: 19584882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults.
    Kallwitz ER; Tayo BO; Kuniholm MH; Cai J; Daviglus M; Cooper RS; Cotler SJ
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2301-2309. PubMed ID: 30743004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.
    Umano GR; Caprio S; Di Sessa A; Chalasani N; Dykas DJ; Pierpont B; Bale AE; Santoro N
    Am J Gastroenterol; 2018 Mar; 113(3):376-383. PubMed ID: 29485130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2013 Feb; 97(2):326-31. PubMed ID: 23269818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
    Romeo S; Kozlitina J; Xing C; Pertsemlidis A; Cox D; Pennacchio LA; Boerwinkle E; Cohen JC; Hobbs HH
    Nat Genet; 2008 Dec; 40(12):1461-5. PubMed ID: 18820647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
    Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
    J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
    Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
    Santoro N; Zhang CK; Zhao H; Pakstis AJ; Kim G; Kursawe R; Dykas DJ; Bale AE; Giannini C; Pierpont B; Shaw MM; Groop L; Caprio S
    Hepatology; 2012 Mar; 55(3):781-9. PubMed ID: 22105854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
    Park JH; Cho B; Kwon H; Prilutsky D; Yun JM; Choi HC; Hwang KB; Lee IH; Kim JI; Kong SW
    Liver Int; 2015 Dec; 35(12):2537-46. PubMed ID: 26148225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
    Lin YC; Chang PF; Hu FC; Yang WS; Chang MH; Ni YH
    J Pediatr; 2011 May; 158(5):740-4. PubMed ID: 21168155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort.
    Wing MR; Ziegler JM; Langefeld CD; Roh BH; Palmer ND; Mayer-Davis EJ; Rewers MJ; Haffner SM; Wagenknecht LE; Bowden DW
    Int J Obes (Lond); 2011 Sep; 35(9):1173-82. PubMed ID: 21102551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.